| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
5 companies
Bay City Capital LLC is a 10% Owner at Viracta Therapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 2 buys and 11 sells.
Estimated insider holdings value: $847.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | XLO Xilio Therapeutics, Inc. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +38.3% | -12.5% | -86.4% | |
| Aug 19, 2020 | MDGL Madrigal Pharmaceuticals, Inc. | 10% Owner | Sell | 30,000 | $109.74 | $3,292,195.83 | -16.4% | - | - | |
| Dec 13, 2019 | MDGL Madrigal Pharmaceuticals, Inc. | 10% Owner | Sell | 1,200,000 | $105.47 | $126,564,000.00 | -22.3% | - | - | |
| Jun 25, 2018 | KZR Kezar Life Sciences, Inc. | 10% Owner | Buy | 150,000 | $15.00 | $2,250,000.00 | +31.8% | - | - | |
| Jun 11, 2018 | MDGL Madrigal Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 280,000 | $287.46 | $80,488,800.00 | -4.9% | - | - | |
| Jul 24, 2015 | VIRX Viracta Therapeutics, Inc. | 10% Owner | Sell | 635,702 | $3.46 | $2,199,528.92 | -2.8% | - | - |